Animal studies have shown improvements in tissue necrosis and the emergence of dystrophin-positive muscle fibers in DMD model mice following intravenous administration of mesenchymal stem cells (MSCs) [8]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.